Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Novartis AG (NOVNEE)

Switzerland
Currency in CHF
93.60
+0.68(+0.73%)
Delayed Data

NOVNEE Income Statement

Advanced Income Statement
Period Ending:
2014
31/12
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa48,67749,89843,97443,46146,660
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.59%+2.51%-11.87%-1.17%+7.36%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa14,42515,12111,39111,29712,020
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa34,25234,77732,58332,16434,640
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+8.43%+1.53%-6.31%-1.29%+7.7%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa70.37%69.7%74.1%74.01%74.24%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa25,16624,62521,62020,95521,998
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+11.03%-2.15%-12.2%-3.08%+4.98%
aa.aaaa.aaaa.aaaa.aaaa.aa9,4028,9808,2598,4259,011
aa.aaaa.aaaa.aaaa.aaaa.aa14,36914,19712,75612,14312,489
aa.aaaa.aaaa.aaaa.aaaa.aa1,3951,448605387498
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa9,08610,15210,96311,20912,642
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1.82%+11.73%+7.99%+2.24%+12.78%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa18.67%20.35%24.93%25.79%27.09%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-605-778-717-423-228
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.47%-28.6%+7.84%+41%+46.1%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-850-869-787-800-855
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa2459170377627
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa45950415,229-248-210
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa8,9409,87825,47510,53812,204
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa--724166225
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa---880-1,445-2,250
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa8,9409,87824,5307,1779,123
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-36.57%+10.49%+148.33%-70.74%+27.11%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa18.37%19.8%55.78%16.51%19.55%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,7931,8071,6251,128551
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa11,7378,07124,0186,95514,854
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-513--4
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa11,7328,07224,0216,95514,850
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-6.97%-31.2%+197.58%-71.05%+113.52%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa24.1%16.18%54.63%16%31.83%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,1428,07222,9086,0498,568
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.123.5410.212.774.13
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-43.49%+13.7%+188.15%-72.85%+48.76%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa3.083.5210.142.764.1
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-43.59%+14.29%+188.07%-72.78%+48.55%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa2,290.792,277.042,242.62,181.182,076.79
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa2,3192,2962,2602,1972,092
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa3.123.393.43.463.92
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+9.86%+8.68%+0.29%+1.77%+13.24%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa13,26714,93215,63315,93617,518
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-6.14%+12.55%+4.69%+1.94%+9.93%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa